CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

Latest News

Imbruvica-Venclexta Combination Demonstrates Benefits in Untreated CLL

December 4th 2023

Results from a four-year follow-up of a phase 3 trial determined that the combination of Imbruvica and Venclexta provided benefits for untreated patients with CLL.

FDA approval: developing story
FDA Approves Jaypirca for Pretreated CLL, SLL

December 2nd 2023

FDA on blue background
FDA Accepts Priority Review for Breyanzi in CLL

November 17th 2023

image of CLL
CLL and Its Treatment Can Heighten Patients’ Risk of Infections

November 8th 2023

image of CLL
Targeted Agents Shift the Landscape of CLL Treatment

November 6th 2023

Video Series
Video Interviews
CURE Talks Cancer podcast
Understanding the Pendulum Swing in CLL Research Over the Last Decade

More News